Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.
about
Biological response modifiers in cancerCell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell linesThe biology of interferon-alpha and the clinical significance of anti-interferon antibodies.Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.Calcium influx and the Ca2+-calmodulin complex are involved in interferon-gamma-induced expression of HLA class II molecules on HL-60 cellsImmune and gene therapy for melanoma, and the immunobiology of melanoma.DNA content and MHC class II antigen expression in malignant melanoma: clinical course.Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes.HLA-DR expression, natural killer cells and IgE containing cells in the jejunal mucosa of coeliac children.Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis.Upstream DNA sequences required for tissue-specific expression of the HLA-DR alpha gene.GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.Oncogenes in melanomas.Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.The immunopathology of sequential tumor biopsies in patients treated with interleukin-2. Correlation of response with T-cell infiltration and HLA-DR expression.HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisitionPhenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cellsExtracellular matrix-modulated expression of human cell surface glycoproteins A42 and J143. Intrinsic and extrinsic signals determine antigenic phenotype.Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses.Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation.Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblastLysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant protein.Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.The MIF receptor CD74 in diabetic podocyte injury.Human cervical epithelial cells that express HLA-DR associated with viral infection and activated mononuclear cell infiltrate.In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon.Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.A melanoma immune response signature including Human Leukocyte Antigen-E.Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cellsGenetic complexity and expression of human class II histocompatibility antigens.Cholera toxin-induced alteration of the phenotype and behaviour of an ovarian carcinoma cell line, SR8.Dissection of the interferon gamma-MHC class II signal transduction pathway reveals that type I and type II interferon systems share common signalling component(s).Effect of interferon-gamma on the expression of HLA-DR by human melanoma cells of varying metastatic potential.Suppression of HLA class II expression on thyrocytes by interferon-alpha 1.Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.Induction of Ia antigens on synovial cells by gamma interferon.Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients.Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon
P2860
Q24685049-A801A7A4-0CE8-49CC-BB95-12E9F8E09E14Q28611880-E1C36329-AEE0-4D7C-A179-50D208EE04F4Q30431132-BF068FBE-1ABA-4314-8992-FE754DAA87C1Q30667174-81426F45-FB81-47AA-98B0-37766AB05774Q33570843-E7597054-27BA-444A-8FD5-C95AF46B5935Q33706946-51D10B1F-56A9-4FA1-96FF-A8C19CF6DD75Q33839538-9EDAA4BC-DF72-4308-B0D5-68F21BE8B6DDQ34373203-A394A969-1194-4ECF-821C-B11B7C2C214EQ34528326-C19CFE14-5E99-496A-8594-AC2301624AB1Q34550337-B880A81C-EA2B-403F-82E7-5D4CE2AAD981Q34632534-351EA0E1-C3A8-42EC-B13D-0B70F821F00FQ34692289-FA5CE5A0-6BF7-408B-98AE-B9445E82A6D3Q35204292-5F7276EA-30C3-4A47-AF5B-A9A85921FDD4Q35836494-9AB32DA0-8C8F-4B52-92EE-7AD4A4B932D7Q35856332-968F2387-CA63-4EA7-A3D2-59BD8B7C2B14Q36184954-B55947FD-4505-40E1-B7FB-B8B9F016CB41Q36352524-17B88C49-AE52-4146-A47E-1B72C3D9136BQ36353103-AFB7724D-F1FF-4DCE-BA9F-4D7DD77EE48FQ36353152-D8F279C2-C6C4-495D-8688-DCA11047C23EQ36354333-3FDB2425-7B6C-49FB-AF03-1445DDC734AEQ36354711-16924A8D-DE9C-40FD-864E-9F6B17A72632Q36356745-93D68916-C151-4E51-8783-F729B115CC8FQ36509692-A7255007-0C83-467D-8825-6F42A441FE80Q36696205-2C9B2CFE-E39B-402D-B64D-2C85C494F5F1Q37086644-0AE29205-5BBC-4D96-97B5-51B49C81CDFCQ37143276-0A06C1F4-5EFD-49EA-815D-2C1924B2125AQ37156248-B3AEFB60-E675-4E77-8466-A9EE1B474A93Q37684679-FDA92D64-B91F-4700-8A38-7C3250E10E74Q38358028-CE8317E8-777A-49AA-8ACF-A42C7432A88AQ38486080-5060F883-BB22-4D1E-804B-48AE1C687031Q39001295-720A3BD0-3871-47AC-A18F-7044CF7C6349Q39830015-2EF3B191-4BF8-4F8A-BCCE-48FCF834930BQ40920794-2EC60FDF-9E13-4793-8FBB-F78E60C93AB5Q41520809-2ABF9BFB-B9D2-4198-87C8-289335A9A019Q41723641-079963B9-3E33-44F5-BF45-EED8F8E95E6AQ41741342-CF194E2D-54D6-4230-9437-3E87FABC2643Q41901851-1E677E4D-1184-43A7-929E-FAC5E64EE8ABQ42499701-45302357-9783-49C5-913D-A681B3A9D377Q42512070-88AC94C9-AA81-484C-8371-9C8A40D5CECEQ42528097-50BF997B-1396-4F8C-9EAB-410081B69B97
P2860
Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Surface antigens of melanoma a ...... ens by human gamma-interferon.
@ast
Surface antigens of melanoma a ...... ens by human gamma-interferon.
@en
type
label
Surface antigens of melanoma a ...... ens by human gamma-interferon.
@ast
Surface antigens of melanoma a ...... ens by human gamma-interferon.
@en
prefLabel
Surface antigens of melanoma a ...... ens by human gamma-interferon.
@ast
Surface antigens of melanoma a ...... ens by human gamma-interferon.
@en
P2093
P2860
P356
P1476
Surface antigens of melanoma a ...... ens by human gamma-interferon.
@en
P2093
P2860
P304
P356
10.1084/JEM.160.1.255
P407
P577
1984-07-01T00:00:00Z